Excellent Paper Award Winner; “Latest Treatment Options to Overcome Acquired Resistance to Osimertinib for EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) After Prior EGFR-TKI Therapies”, Tam Q. Nguyen, Paul E. Lie, Donald Y.C. Lie and Lukman Tijani, Proc. International Conference on Medical and Biosciences (ICMBS) Taipei , Taiwan June 26-27, 2019

Yu-Chun Lie

Excellent Paper Award Winner; “Latest Treatment Options to Overcome Acquired Resistance to Osimertinib for EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) After Prior EGFR-TKI Therapies”, Tam Q. Nguyen, Paul E. Lie, Donald Y.C. Lie and Lukman Tijani, Proc. International Conference on Medical and Biosciences (ICMBS) Taipei , Taiwan June 26-27, 2019

Electrical and Computer Engineering

Research output: Contribution to conference › Paper › peer-review

Original language	English
State	Published - 2019

Fingerprint

Dive into the research topics of 'Excellent Paper Award Winner; “Latest Treatment Options to Overcome Acquired Resistance to Osimertinib for EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) After Prior EGFR-TKI Therapies”, Tam Q. Nguyen, Paul E. Lie, Donald Y.C. Lie and Lukman Tijani, Proc. International Conference on Medical and Biosciences (ICMBS) Taipei , Taiwan June 26-27, 2019'. Together they form a unique fingerprint.

Cite this

Lie, Y-C. (2019). Excellent Paper Award Winner; “Latest Treatment Options to Overcome Acquired Resistance to Osimertinib for EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) After Prior EGFR-TKI Therapies”, Tam Q. Nguyen, Paul E. Lie, Donald Y.C. Lie and Lukman Tijani, Proc. International Conference on Medical and Biosciences (ICMBS) Taipei , Taiwan June 26-27, 2019.

@conference{07fdabbfbf834d05976a4228eea14c19,

title = "Excellent Paper Award Winner; “Latest Treatment Options to Overcome Acquired Resistance to Osimertinib for EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) After Prior EGFR-TKI Therapies”, Tam Q. Nguyen, Paul E. Lie, Donald Y.C. Lie and Lukman Tijani, Proc. International Conference on Medical and Biosciences (ICMBS) Taipei , Taiwan June 26-27, 2019",

author = "Yu-Chun Lie",

year = "2019",

language = "English",

}

Lie, Y-C 2019, 'Excellent Paper Award Winner; “Latest Treatment Options to Overcome Acquired Resistance to Osimertinib for EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) After Prior EGFR-TKI Therapies”, Tam Q. Nguyen, Paul E. Lie, Donald Y.C. Lie and Lukman Tijani, Proc. International Conference on Medical and Biosciences (ICMBS) Taipei , Taiwan June 26-27, 2019'.

Excellent Paper Award Winner; “Latest Treatment Options to Overcome Acquired Resistance to Osimertinib for EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) After Prior EGFR-TKI Therapies”, Tam Q. Nguyen, Paul E. Lie, Donald Y.C. Lie and Lukman Tijani, Proc. International Conference on Medical and Biosciences (ICMBS) Taipei , Taiwan June 26-27, 2019. / Lie, Yu-Chun.
2019.

Research output: Contribution to conference › Paper › peer-review

TY - CONF

T1 - Excellent Paper Award Winner; “Latest Treatment Options to Overcome Acquired Resistance to Osimertinib for EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) After Prior EGFR-TKI Therapies”, Tam Q. Nguyen, Paul E. Lie, Donald Y.C. Lie and Lukman Tijani, Proc. International Conference on Medical and Biosciences (ICMBS) Taipei , Taiwan June 26-27, 2019

AU - Lie, Yu-Chun

PY - 2019

Y1 - 2019

M3 - Paper

ER -